vildagliptin
Showing 1 - 25 of 220
Type 2 Diabetes Trial in Damanhur (Vildagliptin 50 MG, Glimepiride 3 Mg Oral Tablet)
Recruiting
- Type 2 Diabetes
- Vildagliptin 50 MG
- Glimepiride 3 Mg Oral Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 29, 2023
Poly Cystic Ovary Syndrome Trial in Giza (Metformin Hydrochloride tablet, Vildagliptin 50 MG)
Recruiting
- Poly Cystic Ovary Syndrome
- Metformin Hydrochloride tablet
- Vildagliptin 50 MG
-
Giza, EgyptOctober 6 university hospital
Nov 26, 2023
Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
-
Tunis, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023
Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
- Galvumet® Film Coated Tablets (850 mg / 50 mg)
-
Bab Souika, Tunise, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023
Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)
Completed
- Type 2 Diabetes
- Empagliflozin
- Vildagliptin
-
Karachi, Sindh, PakistanDepartment of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022
Schizophrenia, Dyslipidemias Trial in Shibin Al Kawm (Vildagliptin 50 MG, Placebo)
Recruiting
- Schizophrenia
- Dyslipidemias
- Vildagliptin 50 MG
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Feb 8, 2022
Disorder Related to Renal Transplantation, Diabetes Trial in Besançon (Vildagliptin, Placebo)
Recruiting
- Disorder Related to Renal Transplantation
- Diabetes
- Vildagliptin
- Placebo
-
Besançon, FranceCHU de Besançon
Aug 1, 2022
Diabetes Trial (Vildagliptin 50 MG)
Completed
- Diabetes Mellitus
- Vildagliptin 50 MG
- (no location specified)
Apr 14, 2022
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 850/50 mg)
Completed
- To Determine Bioequivalence Under Fed Conditions
- Metformin and Vildagliptin 850/50 mg
- (no location specified)
Apr 16, 2022
To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 1000/50 mg)
Completed
- To Determine Bioequivalence Under Fed Conditions
- Metformin and Vildagliptin 1000/50 mg
- (no location specified)
Apr 14, 2022
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Type 2 Diabetes Trial in Mexico (Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg), Glimepiride / Vildagliptin /
Not yet recruiting
- Type 2 Diabetes
- Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg)
- Glimepiride / Vildagliptin / Metformin (4 mg/ 50 mg/ 1000 mg)
-
Cancún, Quintana Roo, Mexico
- +4 more
Jun 8, 2021
Diabetes, Type 2 Trial in Shinjuku-Ku (Imeglimin, Metformin, Vildagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Imeglimin
- +2 more
-
Shinjuku-Ku, Tokyo, JapanCenter Hospital of the National Center for Global Health and Med
Sep 26, 2022
Diabetes, Type 2 Trial in Minya (Vildagliptin 50 MG, Sitagliptin 100mg, MetFORMIN 1000 Mg Oral Tablet)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin 50 MG
- +2 more
-
Minya, EgyptMinya University Hospital
Jun 4, 2021
Metformin and DPP4 Inhibitors on Cognition and Cardiovascular
Recruiting
- Type 2 Diabetes Mellitus
- Vildagliptin
-
Cairo, Al Kasr Al Aini, EgyptNational Institute of diabetes and endocrinology
Jun 19, 2022
Renal Impairment, Diabetes Trial in Moscow (Vildagliptin)
Completed
- Renal Impairment
- Diabetes
- Vildagliptin
-
Moscow, Russian FederationNovartis Investigator Site
Dec 11, 2020
Thyroid Cancer Trial
Completed
- Thyroid Cancer
- (no location specified)
Jul 2, 2021
Type 2 Diabetes Trial in Tokyo (Vildagliptin (LAF237), Voglibose, Vildagliptin and Voglibose)
Completed
- Type 2 Diabetes
- Vildagliptin (LAF237)
- +2 more
-
Tokyo, JapanNovartis Investigative Site
Dec 16, 2020
Diabetes, Type 2 Trial in Baltimore (Vildagliptin)
Terminated
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Baltimore, MarylandNovartis Investigator Site
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +4 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, Metformin, Vildagliptin + Metformin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in Nurnberg, Basel (vildagliptin, Gliclazide, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +2 more
-
Nurnberg, Germany
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in Basel (vildagliptin, )
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- placebo
-
Basel, SwitzerlandNovartis Pharmaceuticals
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover (Vildagliptin, pioglitazone, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New JerseyNovartis Pharmaceuticals
Dec 11, 2020